Dawson, L. M., Smith, K. N., Werdyani, S., Ndikumana, R., Penney, C., Wiede, L. L., . . . O’Rielly, D. D. (2019). A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect. Mol Genet Genomic Med.
Style de citation ChicagoDawson, Lesa M., et al. "A Dominant RAD51C Pathogenic Splicing Variant Predisposes to Breast and Ovarian Cancer in the Newfoundland Population Due to Founder Effect." Mol Genet Genomic Med 2019.
Style de citation MLADawson, Lesa M., et al. "A Dominant RAD51C Pathogenic Splicing Variant Predisposes to Breast and Ovarian Cancer in the Newfoundland Population Due to Founder Effect." Mol Genet Genomic Med 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.